Join fellow Phase 1 Equity doctor partners in New Orleans for a day focused on connection, collaboration, and the future of Phase 1 Equity. The gathering will include the Q3 Board Meeting, partner discussions, and time to connect with fellow doctors throughout the day.
Please contact Jamie Ritter at jritter@phase1equity.com
Partners should plan to arrive Thursday evening in order to attend the full Friday program.
2 Poydras Street
New Orleans, LA 70130
Covering partner hotel accommodations for the nights of Thursday, October 15 and Friday, October 16.
Breakfast begins at 8:00 AM, with scheduled events continuing through dinner that evening.
Following the Partner Meeting, the group will head to Mardi Gras World for a tour and mixology experience.
Partners should meet in the Hilton lobby at 2:30 PM.
Transportation will be coordinated for the Mardi Gras World experience.
The day will conclude with dinner at Galatoire's in the French Quarter, scheduled from 7:00 – 10:00 PM.
Galatoire's is approximately a 15–20 minute walk from the Hilton, offering an opportunity to enjoy a stroll into the French Quarter on the way to dinner. Guests who prefer not to walk are welcome to arrange individual transportation.
Plan to arrive Thursday, October 15 so you you are available for the full Friday program.
Hilton New Orleans Riverside, 2 Poydras Street, New Orleans, LA 70130.
Thursday, October 15 and Friday, October 16.
Transportation will be coordinated for the Mardi Gras World experience. For dinner at Galatoire’s, guests may enjoy the approximately 15–20 minute walk into the French Quarter or arrange individual transportation if preferred.
Breakfast and lunch will be provided during the Partner Meeting, followed by dinner at Galatoire’s Friday evening.

For over 60 years, Ormco has partnered with orthodontic professionals to advance patient care through innovative products, technologies, and clinical solutions. With a portfolio spanning brackets, wires, aligners, and digital orthodontics, Ormco focuses on helping clinicians achieve predictable, efficient treatment outcomes.
Please contact Jamie Ritter at jritter@phase1equity.com